Who
Alan Lotvin
Director
Company insider
Files Form 4 as: Director, ProKidney; EVP&President-PharmacyServices, CVS Health; President, ICore Healthcare, Magellan Health Services.
In numbers
- Trades disclosed
- 74
- Buys
- 1
- Sells
- 9
- Bought
- $316K
- Sold
- $20.1M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 4 Mar 2010
- Last trade
- 28 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 May 2026filed 29 May 2026 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —135,000 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —135,000 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,862 at $0.00 | filing |
| 30 May 2024filed 3 Jun 2024 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —62,558 at $0.00 | filing |
| 29 Jun 2023filed 3 Jul 2023 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,128 at $0.00 | filing |
| 4 Aug 2022filed 5 Aug 2022 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code M | —22,541 at $0.00 | filing |
| 4 Aug 2022filed 5 Aug 2022 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code M | $1.4M22,541 at $62.21 | filing |
| 4 Aug 2022filed 5 Aug 2022 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Sold | $2.3M22,541 at $104.00 | filing |
| 3 Aug 2022filed 5 Aug 2022 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code M | —70,398 at $0.00 | filing |
| 3 Aug 2022filed 5 Aug 2022 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code M | —50,501 at $0.00 | filing |
| 3 Aug 2022filed 5 Aug 2022 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code M | $4.1M70,398 at $58.34 | filing |
| 3 Aug 2022filed 5 Aug 2022 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Sold | $6.9M70,398 at $98.00 | filing |
| 3 Aug 2022filed 5 Aug 2022 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code M | $2.7M50,501 at $54.19 | filing |
| 3 Aug 2022filed 5 Aug 2022 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Sold | $4.9M50,501 at $98.00 | filing |
| 11 Jul 2022filed 13 Jul 2022 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,514,326 at $0.00 | filing |
| 11 Jul 2022filed 13 Jul 2022 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,514,326 at $0.00 | filing |
| 1 Apr 2022filed 5 Apr 2022 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code A | $7.9M77,962 at $101.09 | filing |
| 1 Apr 2022filed 5 Apr 2022 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code F | $3.9M38,129 at $101.09 | filing |
| 21 Feb 2022filed 23 Feb 2022 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code A | —85,971 at $0.00 | filing |
| 1 Feb 2022filed 2 Feb 2022 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code M | —21,386 at $0.00 | filing |
News
CVS Health (NYSE:CVS) Stock Sees Heavy Call Option BuyingCVS · themarketsdaily.com · 23 Oct 2026CVS Health: How To Prepare Your Household for Cold and Flu SeasonCVS · finanznachrichten.de · 21 Oct 2026CVS Health Collaborates With the Midlife Collective To Redefine a Woman's Midlife Health JourneyCVS · finanznachrichten.de · 20 Oct 2026
0 headlines in the last 90 days name Alan Lotvin; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.